Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Slifstein

Showing results (51-60 of 131) with videos related to

Pageof 14
Sort By:
Molecular Metabolism|March 17, 2019
A role for foregut tyrosine metabolism in glucose toleranceJudith Korner, Gary W Cline, Mark Slifstein, et al.
Biological Psychiatry|July 26, 2018
Dopamine Release in Antidepressant-Naive Major Depressive Disorder: A Multimodal [<sup>11</sup>C]-(+)-PHNO Positron Emission Tomography and Functional Magnetic Resonance Imaging StudyFranklin R Schneier, Mark Slifstein, Alexis E Whitton, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|September 13, 2021
Differential reinforcement learning responses to positive and negative information in unmedicated individuals with depressionJenna M Reinen, Alexis E Whitton, Diego A Pizzagalli, et al.
Biological Psychiatry|October 31, 2008
Positron emission tomography imaging of the serotonin transporter and 5-HT(1A) receptor in alcohol dependenceDiana Martinez, Mark Slifstein, Roberto Gil, et al.
Psychiatry Research|August 15, 2015
Striatal dopamine type 2 receptor availability in anorexia nervosaAllegra Broft, Mark Slifstein, Joseph Osborne, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 29, 2006
Estimation of serotonin transporter parameters with 11C-DASB in healthy humans: reproducibility and comparison of methodsW Gordon Frankle, Mark Slifstein, Roger N Gunn, et al.
Biological Psychiatry|October 22, 2011
Deficits in dopamine D(2) receptors and presynaptic dopamine in heroin dependence: commonalities and differences with other types of addictionDiana Martinez, Phillip A Saccone, Fei Liu, et al.
Biological Psychiatry|February 3, 2024
Imaging the Vesicular Acetylcholine Transporter in Schizophrenia: A Positron Emission Tomography Study Using [<sup>18</sup>F]-VATJodi J Weinstein, Scott J Moeller, Greg Perlman, et al.
Molecular Imaging and Biology|May 3, 2007
In vivo DA D(1) receptor selectivity of NNC 112 and SCH 23390Jesper Ekelund, Mark Slifstein, Raj Narendran, et al.
Psychopharmacology|November 5, 2011
Imaging human reward processing with positron emission tomography and functional magnetic resonance imagingNina B L Urban, Mark Slifstein, Shashwath Meda, et al.
Pageof 14

Showing results (51-60 of 131) with videos related to

Sort By:
Pageof 14
Molecular Metabolism|March 17, 2019
A role for foregut tyrosine metabolism in glucose toleranceJudith Korner, Gary W Cline, Mark Slifstein, et al.
Biological Psychiatry|July 26, 2018
Dopamine Release in Antidepressant-Naive Major Depressive Disorder: A Multimodal [<sup>11</sup>C]-(+)-PHNO Positron Emission Tomography and Functional Magnetic Resonance Imaging StudyFranklin R Schneier, Mark Slifstein, Alexis E Whitton, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|September 13, 2021
Differential reinforcement learning responses to positive and negative information in unmedicated individuals with depressionJenna M Reinen, Alexis E Whitton, Diego A Pizzagalli, et al.
Biological Psychiatry|October 31, 2008
Positron emission tomography imaging of the serotonin transporter and 5-HT(1A) receptor in alcohol dependenceDiana Martinez, Mark Slifstein, Roberto Gil, et al.
Psychiatry Research|August 15, 2015
Striatal dopamine type 2 receptor availability in anorexia nervosaAllegra Broft, Mark Slifstein, Joseph Osborne, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 29, 2006
Estimation of serotonin transporter parameters with 11C-DASB in healthy humans: reproducibility and comparison of methodsW Gordon Frankle, Mark Slifstein, Roger N Gunn, et al.
Biological Psychiatry|October 22, 2011
Deficits in dopamine D(2) receptors and presynaptic dopamine in heroin dependence: commonalities and differences with other types of addictionDiana Martinez, Phillip A Saccone, Fei Liu, et al.
Biological Psychiatry|February 3, 2024
Imaging the Vesicular Acetylcholine Transporter in Schizophrenia: A Positron Emission Tomography Study Using [<sup>18</sup>F]-VATJodi J Weinstein, Scott J Moeller, Greg Perlman, et al.
Molecular Imaging and Biology|May 3, 2007
In vivo DA D(1) receptor selectivity of NNC 112 and SCH 23390Jesper Ekelund, Mark Slifstein, Raj Narendran, et al.
Psychopharmacology|November 5, 2011
Imaging human reward processing with positron emission tomography and functional magnetic resonance imagingNina B L Urban, Mark Slifstein, Shashwath Meda, et al.
Pageof 14